FKBP5 rs9296156: Stress Response and Genetic Variation
The single-nucleotide polymorphism rs9296156 is an intronic tag variant located within the FKBP5 gene on human chromosome 6. It has been investigated for its potential role in modulating the hypothalamic-pituitary-adrenal (HPA) axis, including cortisol awakening dynamics and susceptibility to stress-related conditions. Scientific evidence linking this specific marker to behavioral traits remains limited and subject to complex environmental interactions.
What each genotype means
Typical stress hormone reactivity
You carry two copies of the common G allele in this non-coding region of the FKBP5 gene. Research indicates this genotype is generally associated with typical regulation of the glucocorticoid receptor and an average cortisol awakening response under standard baseline conditions. Because the evidence linking this specific tag variant directly to stress-related traits is limited and often dependent on environmental factors such as life stress, carrying this genotype does not guarantee protection against anxiety or mood disorders.
Carried by approximately 35% to 40% of individuals of European and African ancestries, and is the predominant genotype across most global populations.
Intermediate stress response sensitivity
You carry one copy of the A minor allele and one copy of the G allele. Some research suggests the A allele acts as a tag marker for FKBP5 haplotypes involved in altered stress hormone dynamics, such as differences in cortisol awakening response and heightened sensitivity to environmental stress. However, findings across studies are mixed and indicate that genetic variation at this locus primarily interacts with life events rather than acting as an independent determinant of stress or anxiety.
Carried by roughly 45% to 50% of individuals of European and African descent, representing the most common genotype in these groups.
Altered cortisol awakening response
You carry two copies of the A minor allele in the FKBP5 gene locus. In published association studies, carrying two copies of this haplotype tag has been linked with altered cortisol awakening profiles and modest variations in susceptibility to stress-induced anxiety, particularly when combined with environmental stressors. Evidence for this specific tag variant remains limited and does not serve as a diagnostic marker for any mental health condition.
Carried by approximately 12% to 16% of individuals of European and African ancestries; frequency varies significantly in other populations.
Genomic Location and Variant Characteristics
The rs9296156 polymorphism represents a single-nucleotide variation mapped to an intronic region of the FKBP5 gene on chromosome 6p21.31. In genomic databases such as dbSNP, it is characterized by an exchange between an adenine (A) allele and a guanine (G) allele. Because it lies within a non-coding region, it does not directly alter the amino acid sequence of the resulting protein. Instead, variants in this region often function as tag SNPs or proxy markers that reflect broader haplotype structures across the FKBP5 locus. Intronic variants may also influence regulatory mechanisms, such as alternative splicing or transcriptional enhancer availability. Scientific interest in rs9296156 largely stems from its close linkage with other extensively studied FKBP5 regulatory loci, such as rs1360780, which are known to interact with glucocorticoid response elements.
The Biological Role of FKBP5 in Stress Regulation
The FKBP5 gene encodes the FK506-binding protein 51, a co-chaperone protein that interacts directly with heat shock protein 90 (Hsp90) to modulate glucocorticoid receptor sensitivity. When FKBP5 is bound to the glucocorticoid receptor complex, the receptor exhibits reduced affinity for cortisol, which impedes its translocation into the cell nucleus. Cortisol binding normally triggers an ultra-short intracellular negative feedback loop that stimulates FKBP5 expression, creating a sensitive mechanism to terminate and reset the physiological stress response. Consequently, variations that alter FKBP5 expression levels or baseline induction can impair this physiological feedback loop. This alteration leads to sustained hypothalamic-pituitary-adrenal (HPA) axis activity and altered cortisol responsiveness in central nervous system cells, including astrocytes and neurons.
Current Scientific Evidence and Clinical Strength
Published research evaluating rs9296156 has frequently investigated its relationship with neuroendocrine phenotypes, such as the cortisol awakening response, and behavioral traits like post-traumatic stress and anxiety disorders. However, overall evidence for rs9296156 as an independent, deterministic risk factor remains classified as limited. Most psychiatric genetics studies indicate that FKBP5 variants rarely act alone; instead, their effects are strongly contingent upon gene-by-environment interactions, especially exposure to childhood trauma, severe adversity, or chronic physiological stress. Furthermore, replication across diverse ancestral cohorts has yielded mixed results, with some cohorts demonstrating altered stress reactivity while others show no significant association after correcting for multiple comparisons. As a result, rs9296156 is considered an informative exploratory marker rather than a diagnostic determinant.
Population Frequency and Ancestral Distribution
According to population genomics data from sources like the Genome Aggregation Database (gnomAD), the rs9296156 variant is relatively common worldwide. The minor allele frequency is approximately 0.38 across both European and African continental populations. Because it occurs at high frequencies in healthy reference populations, it fits the typical profile of a common, non-pathogenic human genetic polymorphism. Genotype distributions adhere generally to Hardy-Weinberg equilibrium across large population samples, meaning homozygous reference, heterozygous, and homozygous alternate individuals are all widely represented in healthy populations globally. This widespread distribution underscores that carrying one or more copies of the minor allele is a standard human variation rather than a genetic aberration.
Interpreting Genetic Data Responsibly
Understanding your rs9296156 genotype can offer insight into individual biological differences in HPA-axis regulation, but it carries clear limitations. This genetic marker cannot diagnose depression, post-traumatic stress disorder, or any anxiety disorder, nor can it reliably predict personal resilience. Complex mental health and neuroendocrine traits arise from hundreds of interacting genetic loci combined with life experiences, social support, and lifestyle factors. In pharmacogenomics, while FKBP5 variation has been studied for its relationship to antidepressant outcomes, guidelines from CPIC do not recommend changing medications based solely on this SNP. Any questions regarding stress management, mental health symptoms, or pharmaceutical treatments should always be reviewed directly with a licensed medical professional or clinical pharmacist.
How common is this variant?
The rs9296156 minor allele occurs at an estimated frequency of approximately 0.38 in both European and African continental cohorts according to gnomAD data, making both heterozygous and homozygous genotypes commonplace worldwide.
Frequently asked questions
Does having the rs9296156 variant mean I will develop an anxiety disorder?
No. The rs9296156 variant is not diagnostic of any medical or psychiatric condition. It is a common genetic marker that accounts for a very small fraction of individual physiological variance, and whether stress-related conditions develop depends overwhelmingly on environmental, psychological, and systemic factors.
Can rs9296156 determine which antidepressant I should take?
Currently, no clinical guidelines recommend altering psychiatric prescriptions based on rs9296156 status. While researchers explore FKBP5 in relation to treatment response, validated pharmacogenomic guidelines from bodies like CPIC do not include this variant for medication selection. Any decisions regarding prescription drugs must be made in consultation with a qualified physician or pharmacist.
How does FKBP5 affect the body's cortisol levels?
FKBP5 produces a co-chaperone protein that binds to glucocorticoid receptors and temporarily lowers their sensitivity to cortisol. This mechanism creates an intracellular negative feedback loop that regulates how strongly and for how long the body responds to stress hormones.
Why do some studies show different results for this variant?
FKBP5 variants typically show pronounced gene-environment interactions, meaning their statistical effects often appear only in individuals exposed to significant early-life adversity or chronic trauma. When studies evaluate general populations without accounting for environmental stress levels or ancestral background, associations frequently fail to replicate.
Sources & further reading
Educational information only, last refreshed 9/14/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs9296156?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in FKBP5
This intronic variant in the FKBP5 gene modulates glucocorticoid receptor sensitivity and is linked to altered stress reactivity and susceptibility to psychiatric conditions like PTSD and depression.
Intronic variant in FKBP5; while FKBP5 is a well-established stress-response gene, specific associations for rs4713919 with HPA axis dynamics are less robustly replicated than other variants like rs1360780.
Modulates FKBP5 chaperone expression and alters glucocorticoid receptor sensitivity and negative feedback regulation of the HPA axis.
Regulatory variant in FKBP5 affecting glucocorticoid receptor chaperone activity and susceptibility to stress-related neuropsychiatric outcomes.
Functional polymorphism in FKBP5 that modulates ultradian and stress-induced cortisol secretion and alters recovery trajectories following acute psychological stress.
Intronic regulatory variant within FKBP5 linked to altered glucocorticoid receptor sensitivity and acute cortisol response following psychosocial stress.